Global Long-Acting Injectables Market Size, Status and Forecast 2024-2031

Report ID: 955017 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Small and Middle Sized Molecule
        1.2.3 Large Sized Molecule
    1.3 Market by Application
        1.3.1 Global Long-Acting Injectables Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Schizophrenia
        1.3.3 Other Psychotic Disorders
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Long-Acting Injectables Market Perspective (2016-2027)
    2.2 Long-Acting Injectables Growth Trends by Regions
        2.2.1 Long-Acting Injectables Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Long-Acting Injectables Historic Market Share by Regions (2016-2021)
        2.2.3 Long-Acting Injectables Forecasted Market Size by Regions (2022-2027)
    2.3 Long-Acting Injectables Industry Dynamic
        2.3.1 Long-Acting Injectables Market Trends
        2.3.2 Long-Acting Injectables Market Drivers
        2.3.3 Long-Acting Injectables Market Challenges
        2.3.4 Long-Acting Injectables Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Long-Acting Injectables Players by Revenue
        3.1.1 Global Top Long-Acting Injectables Players by Revenue (2016-2021)
        3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2016-2021)
    3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Long-Acting Injectables Revenue
    3.4 Global Long-Acting Injectables Market Concentration Ratio
        3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2020
    3.5 Long-Acting Injectables Key Players Head office and Area Served
    3.6 Key Players Long-Acting Injectables Product Solution and Service
    3.7 Date of Enter into Long-Acting Injectables Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Long-Acting Injectables Breakdown Data by Type
    4.1 Global Long-Acting Injectables Historic Market Size by Type (2016-2021)
    4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2022-2027)

5 Long-Acting Injectables Breakdown Data by Application
    5.1 Global Long-Acting Injectables Historic Market Size by Application (2016-2021)
    5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Long-Acting Injectables Market Size (2016-2027)
    6.2 North America Long-Acting Injectables Market Size by Type
        6.2.1 North America Long-Acting Injectables Market Size by Type (2016-2021)
        6.2.2 North America Long-Acting Injectables Market Size by Type (2022-2027)
        6.2.3 North America Long-Acting Injectables Market Size by Type (2016-2027)
    6.3 North America Long-Acting Injectables Market Size by Application
        6.3.1 North America Long-Acting Injectables Market Size by Application (2016-2021)
        6.3.2 North America Long-Acting Injectables Market Size by Application (2022-2027)
        6.3.3 North America Long-Acting Injectables Market Size by Application (2016-2027)
    6.4 North America Long-Acting Injectables Market Size by Country
        6.4.1 North America Long-Acting Injectables Market Size by Country (2016-2021)
        6.4.2 North America Long-Acting Injectables Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Long-Acting Injectables Market Size (2016-2027)
    7.2 Europe Long-Acting Injectables Market Size by Type
        7.2.1 Europe Long-Acting Injectables Market Size by Type (2016-2021)
        7.2.2 Europe Long-Acting Injectables Market Size by Type (2022-2027)
        7.2.3 Europe Long-Acting Injectables Market Size by Type (2016-2027)
    7.3 Europe Long-Acting Injectables Market Size by Application
        7.3.1 Europe Long-Acting Injectables Market Size by Application (2016-2021)
        7.3.2 Europe Long-Acting Injectables Market Size by Application (2022-2027)
        7.3.3 Europe Long-Acting Injectables Market Size by Application (2016-2027)
    7.4 Europe Long-Acting Injectables Market Size by Country
        7.4.1 Europe Long-Acting Injectables Market Size by Country (2016-2021)
        7.4.2 Europe Long-Acting Injectables Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Long-Acting Injectables Market Size (2016-2027)
    8.2 Asia-Pacific Long-Acting Injectables Market Size by Type
        8.2.1 Asia-Pacific Long-Acting Injectables Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Long-Acting Injectables Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Long-Acting Injectables Market Size by Type (2016-2027)
    8.3 Asia-Pacific Long-Acting Injectables Market Size by Application
        8.3.1 Asia-Pacific Long-Acting Injectables Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Long-Acting Injectables Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Long-Acting Injectables Market Size by Application (2016-2027)
    8.4 Asia-Pacific Long-Acting Injectables Market Size by Region
        8.4.1 Asia-Pacific Long-Acting Injectables Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Long-Acting Injectables Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Long-Acting Injectables Market Size (2016-2027)
    9.2 Latin America Long-Acting Injectables Market Size by Type
        9.2.1 Latin America Long-Acting Injectables Market Size by Type (2016-2021)
        9.2.2 Latin America Long-Acting Injectables Market Size by Type (2022-2027)
        9.2.3 Latin America Long-Acting Injectables Market Size by Type (2016-2027)
    9.3 Latin America Long-Acting Injectables Market Size by Application
        9.3.1 Latin America Long-Acting Injectables Market Size by Application (2016-2021)
        9.3.2 Latin America Long-Acting Injectables Market Size by Application (2022-2027)
        9.3.3 Latin America Long-Acting Injectables Market Size by Application (2016-2027)
    9.4 Latin America Long-Acting Injectables Market Size by Country
        9.4.1 Latin America Long-Acting Injectables Market Size by Country (2016-2021)
        9.4.2 Latin America Long-Acting Injectables Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Long-Acting Injectables Market Size (2016-2027)
    10.2 Middle East & Africa Long-Acting Injectables Market Size by Type
        10.2.1 Middle East & Africa Long-Acting Injectables Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Long-Acting Injectables Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Long-Acting Injectables Market Size by Type (2016-2027)
    10.3 Middle East & Africa Long-Acting Injectables Market Size by Application
        10.3.1 Middle East & Africa Long-Acting Injectables Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Long-Acting Injectables Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Long-Acting Injectables Market Size by Application (2016-2027)
    10.4 Middle East & Africa Long-Acting Injectables Market Size by Country
        10.4.1 Middle East & Africa Long-Acting Injectables Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Long-Acting Injectables Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Details
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Long-Acting Injectables Introduction
        11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2016-2021)
        11.1.5 Eli Lilly Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Details
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Long-Acting Injectables Introduction
        11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2016-2021)
        11.2.5 Pfizer Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
        11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Long-Acting Injectables Introduction
        11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Lupin
        11.5.1 Lupin Company Details
        11.5.2 Lupin Business Overview
        11.5.3 Lupin Long-Acting Injectables Introduction
        11.5.4 Lupin Revenue in Long-Acting Injectables Business (2016-2021)
        11.5.5 Lupin Recent Development
    11.6 Zogenix
        11.6.1 Zogenix Company Details
        11.6.2 Zogenix Business Overview
        11.6.3 Zogenix Long-Acting Injectables Introduction
        11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2016-2021)
        11.6.5 Zogenix Recent Development
    11.7 DURECT
        11.7.1 DURECT Company Details
        11.7.2 DURECT Business Overview
        11.7.3 DURECT Long-Acting Injectables Introduction
        11.7.4 DURECT Revenue in Long-Acting Injectables Business (2016-2021)
        11.7.5 DURECT Recent Development
    11.8 Medincel
        11.8.1 Medincel Company Details
        11.8.2 Medincel Business Overview
        11.8.3 Medincel Long-Acting Injectables Introduction
        11.8.4 Medincel Revenue in Long-Acting Injectables Business (2016-2021)
        11.8.5 Medincel Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Small and Middle Sized Molecule
    Table 3. Key Players of Large Sized Molecule
    Table 4. Global Long-Acting Injectables Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Long-Acting Injectables Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Long-Acting Injectables Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Long-Acting Injectables Market Share by Regions (2016-2021)
    Table 8. Global Long-Acting Injectables Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Long-Acting Injectables Market Share by Regions (2022-2027)
    Table 10. Long-Acting Injectables Market Trends
    Table 11. Long-Acting Injectables Market Drivers
    Table 12. Long-Acting Injectables Market Challenges
    Table 13. Long-Acting Injectables Market Restraints
    Table 14. Global Long-Acting Injectables Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Long-Acting Injectables Market Share by Players (2016-2021)
    Table 16. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2020)
    Table 17. Ranking of Global Top Long-Acting Injectables Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Long-Acting Injectables Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Long-Acting Injectables Product Solution and Service
    Table 21. Date of Enter into Long-Acting Injectables Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2016-2021)
    Table 25. Global Long-Acting Injectables Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Long-Acting Injectables Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Long-Acting Injectables Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Long-Acting Injectables Revenue Market Share by Application (2016-2021)
    Table 29. Global Long-Acting Injectables Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Long-Acting Injectables Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Long-Acting Injectables Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Long-Acting Injectables Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Long-Acting Injectables Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Long-Acting Injectables Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Long-Acting Injectables Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Long-Acting Injectables Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Long-Acting Injectables Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Long-Acting Injectables Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Eli Lilly Company Details
    Table 62. Eli Lilly Business Overview
    Table 63. Eli Lilly Long-Acting Injectables Product
    Table 64. Eli Lilly Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 65. Eli Lilly Recent Development
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Long-Acting Injectables Product
    Table 69. Pfizer Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. GlaxoSmithKline Company Details
    Table 72. GlaxoSmithKline Business Overview
    Table 73. GlaxoSmithKline Long-Acting Injectables Product
    Table 74. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 75. GlaxoSmithKline Recent Development
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Long-Acting Injectables Product
    Table 79. Johnson & Johnson Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 80. Johnson & Johnson Recent Development
    Table 81. Lupin Company Details
    Table 82. Lupin Business Overview
    Table 83. Lupin Long-Acting Injectables Product
    Table 84. Lupin Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 85. Lupin Recent Development
    Table 86. Zogenix Company Details
    Table 87. Zogenix Business Overview
    Table 88. Zogenix Long-Acting Injectables Product
    Table 89. Zogenix Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 90. Zogenix Recent Development
    Table 91. DURECT Company Details
    Table 92. DURECT Business Overview
    Table 93. DURECT Long-Acting Injectables Product
    Table 94. DURECT Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 95. DURECT Recent Development
    Table 96. Medincel Company Details
    Table 97. Medincel Business Overview
    Table 98. Medincel Revenue in Long-Acting Injectables Business (2016-2021) & (US$ Million)
    Table 99. Medincel Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Long-Acting Injectables Market Share by Type: 2020 VS 2027
    Figure 2. Small and Middle Sized Molecule Features
    Figure 3. Large Sized Molecule Features
    Figure 4. Global Long-Acting Injectables Market Share by Application: 2020 VS 2027
    Figure 5. Schizophrenia Case Studies
    Figure 6. Other Psychotic Disorders Case Studies
    Figure 7. Long-Acting Injectables Report Years Considered
    Figure 8. Global Long-Acting Injectables Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Long-Acting Injectables Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Long-Acting Injectables Market Share by Regions: 2020 VS 2027
    Figure 11. Global Long-Acting Injectables Market Share by Regions (2022-2027)
    Figure 12. Global Long-Acting Injectables Market Share by Players in 2020
    Figure 13. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-Acting Injectables as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2020
    Figure 15. Global Long-Acting Injectables Revenue Market Share by Type (2016-2021)
    Figure 16. Global Long-Acting Injectables Revenue Market Share by Type (2022-2027)
    Figure 17. North America Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Long-Acting Injectables Market Share by Type (2016-2027)
    Figure 19. North America Long-Acting Injectables Market Share by Application (2016-2027)
    Figure 20. North America Long-Acting Injectables Market Share by Country (2016-2027)
    Figure 21. United States Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Long-Acting Injectables Market Share by Type (2016-2027)
    Figure 25. Europe Long-Acting Injectables Market Share by Application (2016-2027)
    Figure 26. Europe Long-Acting Injectables Market Share by Country (2016-2027)
    Figure 27. Germany Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Long-Acting Injectables Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Long-Acting Injectables Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Long-Acting Injectables Market Share by Region (2016-2027)
    Figure 37. China Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Long-Acting Injectables Market Share by Type (2016-2027)
    Figure 45. Latin America Long-Acting Injectables Market Share by Application (2016-2027)
    Figure 46. Latin America Long-Acting Injectables Market Share by Country (2016-2027)
    Figure 47. Mexico Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Long-Acting Injectables Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Long-Acting Injectables Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Long-Acting Injectables Market Share by Country (2016-2027)
    Figure 53. Turkey Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Long-Acting Injectables Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 57. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 60. Lupin Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 61. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 62. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 63. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2016-2021)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Frequently Asked Questions
Long-Acting Injectables report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Long-Acting Injectables report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Long-Acting Injectables report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports